Salina Fisiológica Grifols 0

DRUG4 trials

Conditions

Acute pancreatitisLiver cirrhosisPatients undergoing elective cardiac valve surgery and/or coronary artery bypass grafting with cardiopulmonary bypassat risk of systemic inflammatory response and related postoperative complications.

Phase 2

Evaluation of the effect of intravenous lidocaine on the systemic inflammatory response associated with cardiopulmonary bypass in patients undergoing elective valvular and coronary cardiac surgery: A randomized double-blind clinical trial.

RecruitingCTIS2025-523534-11-00

Hospital San Pedroat risk of systemic inflammatory response and related postoperative complications., Patients undergoing elective cardiac valve surgery and/or coronary artery bypass grafting with cardiopulmonary bypass

Start: 2025-12-15Target: 90Updated: 2025-11-19

Phase 3

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

WithdrawnCTIS2022-501006-34-00

Odense University Hospital, European Foundation For The Study Of Chronic Liver FailureLiver cirrhosis

Target: 180Updated: 2022-10-05

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

RecruitingCTIS2022-501006-34-01

Odense University Hospital, European Foundation For The Study Of Chronic Liver FailureLiver cirrhosis

Start: 2023-03-29Target: 210Updated: 2025-10-07

Phase 4

Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial

CompletedCTIS2023-509879-16-00

Hospital General Universitario Dr. BalmisAcute pancreatitis

End: 2024-08-30Target: 100Updated: 2024-05-17

Related Papers

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial